News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,438 signal articles · 135 in last 24h · 154,019 total before filter · latest 58m ago

135last 24h

869last 7d

144● bullish (7d)

99● bearish (7d)

214publishers

All Macro207 Earnings105 M&A125 Regulatory22 Product21 Analyst16

✕ clear all filtersticker: HALOsentiment: bullishSentiment:bullish neutral bearish show all (incl. clickbait)

Simply Wall St.47d agobullish

Is Halozyme Therapeutics (HALO) Fairly Valued As Earnings Beat And Guidance Rise?

Halozyme earnings beat and guidance hike reshape the story Halozyme Therapeutics (HALO) just put fresh numbers on the table, reporting second quarter 2026 results, raising full year revenue guidance and updating progress on its share repurchase programs. For the quarter ended June 30, 2026, revenue was reported at US$481 million compared with US$325.72 million for the same period a year earlier. Net income for the quarter was US$229.91 million compared with US$165.16 million a year ago. Basic...

HALO

Investor's Business Daily48d agobullish

Stock Market Today: Dow Rises Ahead Of Pivotal Jobs Report; AI Stock Cloudflare Soars On Earnings (Live Coverage)

Stock Market Today: The Dow Jones index rises Friday ahead of a pivotal July jobs report. AI name Cloudflare stock soars on earnings.

ABNB AMZN COHR CRM HALO LITE MCHP NEM+12

Investor's Business Daily57d agobullish

This Medical Technology Stock Claws Back To A Buy Zone

This medical technology name has a patented method of drug delivery. Halozyme stock recently hit a record high with earnings due out soon.

HALO

Zacks140d agobullish

ImmunityBio (IBRX) Reports Q1 Loss, Tops Revenue Estimates

ImmunityBio (IBRX) delivered earnings and revenue surprises of -12.50% and +7.56%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

HALO IBRX